Itron (NASDAQ:ITRI) Price Target Increased to $112.00 by Analysts at Roth Mkm

Itron (NASDAQ:ITRI) had its target price hoisted by Roth Mkm from $102.00 to $112.00 in a research note released on Friday morning, Benzinga reports. The brokerage currently has a buy rating on the scientific and technical instruments company’s stock.

Several other research analysts have also recently commented on the stock. Raymond James cut shares of Itron from an outperform rating to a market perform rating in a report on Thursday, January 4th. TD Cowen upped their target price on Itron from $110.00 to $115.00 and gave the company a buy rating in a research report on Friday. Robert W. Baird increased their target price on Itron from $108.00 to $115.00 and gave the stock an outperform rating in a report on Wednesday, March 13th. Canaccord Genuity Group raised Itron from a hold rating to a buy rating and boosted their price target for the company from $68.00 to $105.00 in a research note on Tuesday, February 27th. Finally, JPMorgan Chase & Co. raised their target price on shares of Itron from $77.00 to $92.00 and gave the company a neutral rating in a report on Wednesday, March 13th. Four investment analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of Moderate Buy and a consensus target price of $104.18.

Itron Stock Performance

NASDAQ:ITRI opened at $107.37 on Friday. The stock has a 50 day simple moving average of $92.26 and a 200 day simple moving average of $77.98. The stock has a market cap of $4.93 billion, a P/E ratio of 30.85, a PEG ratio of 1.16 and a beta of 1.38. Itron has a 1-year low of $56.11 and a 1-year high of $108.60. The company has a current ratio of 1.90, a quick ratio of 1.40 and a debt-to-equity ratio of 0.33.

Itron (NASDAQ:ITRI) last posted its earnings results on Thursday, May 2nd. The scientific and technical instruments company reported $1.24 earnings per share for the quarter, topping analysts’ consensus estimates of $0.85 by $0.39. Itron had a return on equity of 14.51% and a net margin of 7.03%. The company had revenue of $603.44 million during the quarter, compared to the consensus estimate of $579.49 million. During the same quarter last year, the firm earned $0.49 earnings per share. The company’s revenue was up 22.0% on a year-over-year basis. Research analysts anticipate that Itron will post 3.68 earnings per share for the current year.

Insider Buying and Selling

In other Itron news, SVP Donald L. Reeves III sold 383 shares of the stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $75.37, for a total value of $28,866.71. Following the completion of the transaction, the senior vice president now directly owns 8,708 shares in the company, valued at $656,321.96. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, SVP Donald L. Reeves III sold 383 shares of the firm’s stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $75.37, for a total transaction of $28,866.71. Following the completion of the transaction, the senior vice president now owns 8,708 shares of the company’s stock, valued at $656,321.96. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Donald L. Reeves III sold 536 shares of the stock in a transaction on Monday, February 26th. The shares were sold at an average price of $87.10, for a total value of $46,685.60. Following the completion of the sale, the senior vice president now owns 17,425 shares of the company’s stock, valued at $1,517,717.50. The disclosure for this sale can be found here. Insiders have sold 30,467 shares of company stock worth $2,752,520 in the last 90 days. Insiders own 1.45% of the company’s stock.

Institutional Trading of Itron

Several institutional investors have recently added to or reduced their stakes in ITRI. Quantbot Technologies LP raised its holdings in Itron by 186.0% during the 1st quarter. Quantbot Technologies LP now owns 36,260 shares of the scientific and technical instruments company’s stock worth $3,355,000 after purchasing an additional 23,581 shares during the last quarter. Texas Permanent School Fund Corp raised its stake in Itron by 1.3% during the first quarter. Texas Permanent School Fund Corp now owns 39,815 shares of the scientific and technical instruments company’s stock worth $3,684,000 after buying an additional 516 shares during the last quarter. BI Asset Management Fondsmaeglerselskab A S lifted its holdings in Itron by 293.4% in the first quarter. BI Asset Management Fondsmaeglerselskab A S now owns 4,198 shares of the scientific and technical instruments company’s stock valued at $388,000 after buying an additional 3,131 shares during the period. Jennison Associates LLC boosted its position in Itron by 19.3% during the first quarter. Jennison Associates LLC now owns 5,625 shares of the scientific and technical instruments company’s stock valued at $520,000 after acquiring an additional 909 shares during the last quarter. Finally, Janney Montgomery Scott LLC acquired a new stake in Itron during the 1st quarter worth about $346,000. 96.19% of the stock is currently owned by institutional investors.

About Itron

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.